CorMedix (CRMD) Cash & Current Investments (2010 - 2026)
CorMedix's Cash & Current Investments was $256.69 million in Q2 2026, up 34.6% from $190.71 million a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at CorMedix came in at $148.53 million, up 187.4% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 26.2% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $51.69 million in FY2024 (-32.0%), $76.03 million in FY2023 (+29.3%), $58.79 million in FY2022 (-10.2%) and $65.47 million in FY2021 (+41.2%).
- The Q2 2026 figure marks the highest quarterly Cash & Current Investments in data going back to Q2 2010.
- Compared with a year earlier, Cash & Current Investments was higher in five of the last seven quarters, with growth averaging 73.8%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q2 2025 (growth of 318.1%); the worst was Q3 2024 (a decline of 46.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | CorMedix | 558.43 Mn | -94.09 Mn | 77.13 Mn | 256.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256.69 Mn |
| Dec 31, 2025 | 148.53 Mn |
| Sep 30, 2025 | 56.58 Mn |
| Jun 30, 2025 | 190.71 Mn |
| Mar 31, 2025 | 77.50 Mn |
| Dec 31, 2024 | 51.69 Mn |
| Sep 30, 2024 | 46.03 Mn |
| Jun 30, 2024 | 45.61 Mn |
| Mar 31, 2024 | 58.55 Mn |
| Dec 31, 2023 | 76.03 Mn |
| Sep 30, 2023 | 86.59 Mn |
| Jun 30, 2023 | 52.40 Mn |
| Mar 31, 2023 | 55.60 Mn |
| Dec 31, 2022 | 58.79 Mn |
| Sep 30, 2022 | 59.00 Mn |
| Jun 30, 2022 | 64.62 Mn |
| Mar 31, 2022 | 61.69 Mn |
| Dec 31, 2021 | 65.47 Mn |
| Sep 30, 2021 | 71.97 Mn |
| Jun 30, 2021 | 78.25 Mn |
API Access
CorMedix Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();